First Dallas Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,613
Closed -$234K 109
2018
Q3
$234K Hold
2,613
0.15% 92
2018
Q2
$208K Sell
2,613
-50
-2% -$4.15K 0.13% 98
2018
Q1
$238K Hold
2,663
0.16% 97
2017
Q4
$278K Buy
2,663
+875
+49% +$98.7K 0.18% 90
2017
Q3
$261K Sell
1,788
-1,000
-36% -$136K 0.18% 92
2017
Q2
$362K Hold
2,788
0.26% 76
2017
Q1
$347K Sell
2,788
-3,744
-57% -$448K 0.24% 78
2016
Q4
$756K Sell
6,532
-1,000
-13% -$111K 0.52% 47
2016
Q3
$787K Hold
7,532
0.58% 43
2016
Q2
$743K Sell
7,532
-100
-1% -$10.3K 0.57% 39
2016
Q1
$764K Hold
7,632
0.62% 41
2015
Q4
$914K Sell
7,632
-1,000
-12% -$116K 0.75% 34
2015
Q3
$933K Buy
8,632
+350
+4% +$43.4K 0.77% 35
2015
Q2
$958K Buy
8,282
+100
+1% +$11.4K 0.69% 35
2015
Q1
$943K Buy
8,182
+788
+11% +$94.2K 0.66% 36
2014
Q4
$827K Hold
7,394
0.54% 42
2014
Q3
$701K Buy
+7,394
New +$667K 0.42% 51

Other funds holding CELG

First Dallas Securities's CELG Position: Q4 2018 in Review

First Dallas Securities sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,613 shares — an estimated $234K sold.

First Dallas Securities first reported a position in CELG in Q3 2014 and held it in 17 quarters. The position peaked at $958K in Q2 2015. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • First Dallas Securities reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • First Dallas Securities sold 2,613 Celgene Corp shares in Q4 2018, an estimated $234K.
  • First Dallas Securities first reported a position in Celgene Corp in Q3 2014 and held it in 17 quarters.
  • First Dallas Securities's Celgene Corp position peaked at $958K in Q2 2015.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on First Dallas Securities's 13F filing for Q4 2018, filed 11 Feb 2019.